Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Original Discount Agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (Combination Of Active Ingredients)

Techniker Krankenkasse Germany has Released a tender for Open House Original Discount Agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (Combination Of Active Ingredients) in Pharmaceuticals. The tender was released on Oct 13, 2025.

Country - Germany

Summary - Open House Original Discount Agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (Combination Of Active Ingredients)

Deadline - Nov 30, 2027

GT reference number - 120047755

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 120047755

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The TK pursues the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 SGB V for the active ingredient combination doravirine/lamivudine/tenofovir. The contract is concluded as part of TK's Open House Originals procedure: individual negotiations regarding contract contents are not conducted; uniform conditions apply. TK does not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on December 1st, 2025. The contract ends on November 30, 2027 at the latest, regardless of the date the contract was concluded. If the patent expires/market exclusivity e

Gt Ref Id - 120047755

Deadline - Nov 30, 2027

Share share

Similar Tenders :

Summary:
Summary:
Summary:
Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database